These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38367704)

  • 21. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.
    Huang SW; Wang SF
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
    Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
    Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses.
    Sims JJ; Lian S; Meggersee RL; Kasimsetty A; Wilson JM
    PLoS One; 2022; 17(8):e0271359. PubMed ID: 36006993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.
    Gan M; Cao J; Zhang Y; Fu H; Lin X; Ouyang Q; Xu X; Yuan Y; Fan X
    J Med Virol; 2024 Feb; 96(2):e29452. PubMed ID: 38314852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC).
    Tyagi N; Sardar R; Gupta D
    PeerJ; 2022; 10():e13562. PubMed ID: 35765592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
    Tan TS; Toyoda M; Ode H; Barabona G; Hamana H; Kitamatsu M; Kishi H; Motozono C; Iwatani Y; Ueno T
    J Virol; 2022 Oct; 96(20):e0116222. PubMed ID: 36214577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects.
    Elko EA; Mead HL; Nelson GA; Zaia JA; Ladner JT; Altin JA
    Microbiol Spectr; 2024 Feb; 12(2):e0329123. PubMed ID: 38189279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
    Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
    Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
    Matveev EV; Ponomarev GV; Kazanov MD
    Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
    Robson B
    Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein.
    Feng S; O'Brien A; Chen DY; Saeed M; Baker SC
    mBio; 2023 Aug; 14(4):e0068823. PubMed ID: 37477426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy.
    Yang Z; Han Y; Ding S; Shi W; Zhou T; Finzi A; Kwong PD; Mothes W; Lu M
    mBio; 2021 Feb; 13(1):e0322721. PubMed ID: 35164561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021.
    Alkhatib M; Svicher V; Salpini R; Ambrosio FA; Bellocchi MC; Carioti L; Piermatteo L; Scutari R; Costa G; Artese A; Alcaro S; Shafer R; Ceccherini-Silberstein F
    Microbiol Spectr; 2021 Dec; 9(3):e0109621. PubMed ID: 34787497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.
    Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR
    BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.
    Ren W; Zhang Y; Rao J; Wang Z; Lan J; Liu K; Zhang X; Hu X; Yang C; Zhong G; Zhang R; Wang X; Shan C; Ding Q
    mBio; 2023 Apr; 14(2):e0041623. PubMed ID: 37010428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.
    Souza PFN; Mesquita FP; Amaral JL; Landim PGC; Lima KRP; Costa MB; Farias IR; Lima LB; Montenegro RC
    Int J Biol Macromol; 2021 May; 179():1-19. PubMed ID: 33667553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.